<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00940979</url>
  </required_header>
  <id_info>
    <org_study_id>LTC 625-230609</org_study_id>
    <nct_id>NCT00940979</nct_id>
  </id_info>
  <brief_title>Trial Using Integuseal as Microbial Sealant for Arterial Bypass Surgery on Lower Extremities</brief_title>
  <acronym>ITT</acronym>
  <official_title>Prospective Randomised Trial Using Integuseal as Microbial Sealant for Arterial Bypass Surgery on Lower Extremities</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rijnstate Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Kimberly-Clark Corporation</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Rijnstate Hospital</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to prove a reduction of postoperative wound infections after
      direct preoperative use of a microbial sealant in the form of Integuseal for vascular
      procedures on lower extremities.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Interim analyses showed insufficient result. Termination for reasons of futility
  </why_stopped>
  <start_date>January 2010</start_date>
  <completion_date type="Actual">May 2011</completion_date>
  <primary_completion_date type="Actual">April 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative wound infections</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Costs of the use of Integuseal</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications during hospital stay</measure>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">450</enrollment>
  <condition>Arterial Obstructive Diseases</condition>
  <arm_group>
    <arm_group_label>No use of integuseal</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Use of Integuseal</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Application of a layer of Integuseal (Cyanoacrylate) from a ready to use applicator preoperative before incision Polymerisation immobilise the bacteria that survived the conventional skin preparation This way there will be les contamination of the wound.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Application of Integuseal sealant</intervention_name>
    <description>Microbial sealant (integuseal) applied with a sponge applicator</description>
    <arm_group_label>Use of Integuseal</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  planned supragenual of infragenual peripheral arterial bypass procedures with
             autologue or prosthetic graft

        Exclusion Criteria:

          -  secondary procedures and suprainguinal procedures
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michel MPJ Reijnen, MD</last_name>
    <role>Study Director</role>
    <affiliation>Rijstate hospital Arnhem the Netherlands</affiliation>
  </overall_official>
  <overall_official>
    <last_name>J. Klinkenbijl, MD</last_name>
    <role>Study Director</role>
  </overall_official>
  <overall_official>
    <last_name>Sjoerd A de Beer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rijnstate Hospital Arnhem the Netherlands</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ziekenhuis Rijnstate</name>
      <address>
        <city>Arnhem</city>
        <zip>6800 TA</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ziekenhuis Slingland</name>
      <address>
        <city>Doetinchem</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ziekenhuis Nij Smellinghe</name>
      <address>
        <city>Drachten</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 16, 2009</study_first_submitted>
  <study_first_submitted_qc>July 16, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 17, 2009</study_first_posted>
  <last_update_submitted>January 10, 2014</last_update_submitted>
  <last_update_submitted_qc>January 10, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 13, 2014</last_update_posted>
  <keyword>Integuseal microbial sealant</keyword>
  <keyword>Infection prophylaxis</keyword>
  <keyword>Postoperative wound infection</keyword>
  <keyword>Arterial bypass surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arterial Occlusive Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

